Nasser Haydar A, Kansoun Alaa H, Sleiman Youssef A, Mendes Vanessa Marron, Van Vyve Etienne, Kachi Antoine, Berjawi Tarek, Hamdan Wajdi S, El Nakadi Issam
a Faculty of Medical Sciences, Department of General and Digestive Surgery , Lebanese University , Beirut , Lebanon.
b Department of General and Digestive Surgery , Université Libre de Bruxelles (ULB) , Brussels , Belgium.
Acta Chir Belg. 2018 Aug;118(4):212-218. doi: 10.1080/00015458.2018.1459363. Epub 2018 Apr 10.
The first laparoscopic treatment of splenic artery aneurysm (SAA) was performed in 1993. Since then, many papers have been published mentioning different laparoscopic treatment modalities, including splenectomy, aneurysmectomy, ligation or even occlusion.
An updated literature review of the English medical literature using the following MeSH, 'Lapaorscopic splenic artery aneurysm', 'laparoscopic aneurysectomy', 'Laparoscopic Splenic artery Aneurysm Ligation' and 'Laparoscopic Splenic artery aneurysm excision' was done. Also three cases performed at our institutions are discussed, in terms of techniques, morbidity, mortality and postoperative outcomes.
About eight case series and 16 case reports were retrieved from the literature. Different techniques were described by the authors, including splenectomy, aneurysmectomy, splenic aneurysm ligation or even occlusion. Few morbidity cases were reported and none of the authors has mentioned a single mortality case. In our three cases, the postoperative course was uneventful, with good long-term results.
Despite the variations in the adopted operative techniques, the laparoscopic approach seems to be harmless. However, no treatment algorithm or consensus has been published.
1993年首次进行了腹腔镜下脾动脉瘤(SAA)治疗。从那时起,发表了许多论文,提及了不同的腹腔镜治疗方式,包括脾切除术、动脉瘤切除术、结扎甚至封堵术。
使用以下医学主题词(MeSH)对英文医学文献进行了更新的文献综述,即“腹腔镜脾动脉瘤”“腹腔镜动脉瘤切除术”“腹腔镜脾动脉动脉瘤结扎术”和“腹腔镜脾动脉动脉瘤切除术”。此外,还讨论了在我们机构进行的3例病例,涉及技术、发病率、死亡率和术后结果。
从文献中检索到约8个病例系列和16例病例报告。作者描述了不同的技术,包括脾切除术、动脉瘤切除术、脾动脉瘤结扎术甚至封堵术。报告的发病病例很少,且没有作者提及过死亡病例。在我们的3例病例中,术后过程顺利,长期效果良好。
尽管所采用的手术技术存在差异,但腹腔镜方法似乎是安全无害的。然而,尚未发表治疗方案或共识。